
The pharma industry is one of the most lucrative sectors in the global economy, with a high demand for innovative drugs and treatments. Over the last five years, worldwide medicine spending has increased by 35%, with a projected 38% increase through 2028 due to rising demand.
Given the industry’s bright prospects, investors could consider buying fundamentally strong pharmaceutical stocks such as Dr. Reddy’s Laboratories Limited (RDY), Teva Pharmaceutical Industries Limited (TEVA), and AbbVie Inc. (ABBV).